Research location

Nanchong

Sichuan, China

Published trials32

Site observations32

Linked trials published32

Page1 / 1

Research activity in Nanchong

Sichuan, China

CureCurrent currently publishes aggregate city-level research activity for this location: 32 trials and 32 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Nanchong

32 linked trials · page 1 of 1

Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung CancerNCT07855965 · 2026-09-10 · 1 site observation

TQB2930 Injection for the Treatment of HER2-positive Advanced Breast CancerNCT07047365 · 2025-07-25 · 1 site observation

Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast CancerNCT07008976 · 2025-07-07 · 1 site observation

Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung CancerNCT06121505 · 2024-03-01 · 1 site observation

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)NCT06136624 · 2023-12-31 · 1 site observation

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)NCT06136650 · 2023-12-18 · 1 site observation

The Chinese Familial Alzheimer's NetworkNCT03657732 · 2005-01-10 · 1 site observation

China Cognition and Aging StudyNCT03653156 · 2000-01-01 · 1 site observation

Left Ventricular Myocardial Work for Predicting Response to CRTNCT07319065 · 2026-01-01 · 1 site observation

NOT_YET_RECRUITING

Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07147946 · 2025-09-01 · 1 site observation

NOT_YET_RECRUITING

A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid ArthritisNCT07100938 · 2025-08-21 · 1 site observation

A Clinical Trial of TQB2102 for Injection in the Treatment of HER2 Low-Expressing Recurrent/Metastatic Breast CancerNCT06561607 · 2024-10-11 · 1 site observation

ACTIVE_NOT_RECRUITING

Multi-Disciplinary Treatment on the Anthropomorphism of Large Language ModelsNCT06627985 · 2024-10-01 · 1 site observation

NOT_YET_RECRUITING

Assessment of Probiotics on Inflammation and Metabolism in Type 2 Diabetes.NCT06440486 · 2024-06-15 · 1 site observation

PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBCNCT06419621 · 2024-06-11 · 1 site observation

ACTIVE_NOT_RECRUITING

Evaluating the Potential of Large Language Models for Respiratory Disease ConsultationsNCT06457269 · 2023-10-01 · 1 site observation

Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.NCT05922345 · 2023-06-08 · 1 site observation

A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)NCT05288166 · 2022-04-14 · 1 site observation

ACTIVE_NOT_RECRUITING

China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)NCT05221580 · 2022-03-18 · 1 site observation

To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan IsoproxilNCT06500689 · 2021-12-30 · 1 site observation

Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung CancerNCT04952597 · 2021-07-15 · 1 site observation

A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung CancerNCT04746924 · 2021-05-24 · 1 site observation

A Study to Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSCLCNCT04416035 · 2020-08-17 · 1 site observation

Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung CancerNCT03571126 · 2019-05-09 · 1 site observation

A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung CancerNCT04641754 · 2019-03-07 · 1 site observation

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 DiabetesNCT03811288 · 2018-12-10 · 1 site observation

A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate CancerNCT03706365 · 2018-11-26 · 1 site observation

ACTIVE_NOT_RECRUITING

Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung CancerNCT03588494 · 2018-08-01 · 1 site observation

Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in ChinaNCT03156985 · 2017-08-16 · 1 site observation

Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)NCT03416231 · 2016-11-30 · 1 site observation

Compare Efficacy, Safety and Immunogenicity of HLX02 and Herceptin in Previously Untreated HER2 +Overexpressing Metastatic Breast CancerNCT03084237 · 2016-11-01 · 1 site observation

Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In ChinaNCT01176916 · 2011-02-09 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.